Overview

• Europe’s medicines regulator said guidance in the EU is unchanged, allowing paracetamol in pregnancy when needed at the lowest effective dose for the shortest time.
• EMA noted extensive pregnancy data show no increased risk of fetal or newborn malformations with paracetamol.
• WHO stated that research on a prenatal paracetamol–autism link is not consistent and urged caution in drawing conclusions.
• U.S. coverage reports the FDA plans a warning label citing a possible association, following President Trump’s public exhortation to avoid Tylenol during pregnancy.
• Kenvue, the Tylenol maker, and former WHO chief scientist Soumya Swaminathan said there is no credible evidence of causation and cautioned against panic or riskier alternatives.